Terms ending in 2027
Every in-force patent on Givaudan S.A.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,823,894 | Independent Suspension for a Motor Vehicle In force · High confidence | Sistemi Sospensioni S.P.A. | In force | High confidence | |
| US 7,655,701 | Cycloalkylidene-(ortho Substituted Phenyl)-Acetonitriles and Their Use as Odorants In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 10,221,136 | Pyridinyl Cyclohexanecarboxamide Cooling Compounds In force · Medium confidence | Givaudan S.A. | In force | Medium confidence | |
| US 9,057,041 | Fragrance Compounds In force · Medium confidence | Givaudan S.A. | In force | Medium confidence | |
| US 9,585,362 | Fragrance Compounds In force · Medium confidence | Givaudan S.A. | In force | Medium confidence | |
| US 7,964,376 | Chimeric Proteins and Their Use in Methods to Screen for Sweet Taste Modulators In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 8,124,361 | Methods of screening for sweet taste modulators In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 10,722,607 | Perfume Compositions In force · Medium confidence | Givaudan S.A. | In force | Medium confidence | |
| US 8,039,233 | Nucleic Acid Sequences and Their Use in Methods to Identify Umami Modulatiors In force · High confidence | Givaudan S.A. | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
8 of these are in force and held by Givaudan S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.